SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort

J Neurol. 2022 Mar;269(3):1133-1137. doi: 10.1007/s00415-021-10818-w. Epub 2021 Oct 5.

Katharina Eisenhut^{1

2}, Stefan Buchka^{3

4}, Peter Eichhorn⁵, Harald Meier^{4

6}, Fady Albashiti^{4

6}, Ulrich Mansmann^{3

4}, Miriam Schlüter^{1

2}, Joachim Havla^#^{1

2

4}, Tania Kümpfel^#^{7

8}

¹ Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
² Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany.
³ Institute of Medical Information Processing, Biometry, and Epidemiology, Faculty of Medicine, LMU Munich, Munich, Germany.
⁴ Data Integration for Future Medicine (DIFUTURE) Consortium, LMU Munich, Munich, Germany.
⁵ Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.
⁶ Medical Technology and IT (MIT), University Hospital, LMU Munich, Munich, Germany.
⁷ Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. tania.kuempfel@med.uni-muenchen.de.
⁸ Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany. tania.kuempfel@med.uni-muenchen.de.

^# Contributed equally.

No abstract available

Publication types